WEBVTT - This Drug Maker Saw the Pandemic Coming

0:00:03.200 --> 0:00:08.480
<v Speaker 1>Welcome to Prognosis. I'm Laura Carlson. It's stay sixty four.

0:00:08.640 --> 0:00:13.280
<v Speaker 1>Since coronavirus was declared a global pandemic our main story.

0:00:14.280 --> 0:00:17.840
<v Speaker 1>Many governments and companies were caught off guard by the

0:00:17.920 --> 0:00:23.439
<v Speaker 1>devastating spread of the coronavirus. But Gilliad Sciences was different.

0:00:24.480 --> 0:00:28.320
<v Speaker 1>The company had vials of its experimental COVID nineteen drug

0:00:28.440 --> 0:00:32.720
<v Speaker 1>from Desevere ready to put into a clinical trial, and

0:00:32.960 --> 0:00:36.400
<v Speaker 1>it had everything it needed to spring into production when

0:00:36.400 --> 0:00:40.720
<v Speaker 1>the drug was approved for emergency use. How did gill

0:00:40.800 --> 0:00:47.000
<v Speaker 1>Lead anticipate what so many others missed? But first, here's

0:00:47.000 --> 0:00:58.080
<v Speaker 1>what happened today. For the eighth straight week, the number

0:00:58.080 --> 0:01:02.480
<v Speaker 1>of Americans seeking unemployment and totaled in the millions as

0:01:02.480 --> 0:01:07.559
<v Speaker 1>the economy continued to reel from the pandemic. Nearly three

0:01:07.640 --> 0:01:11.679
<v Speaker 1>million people filed initial jobless claims last week, and while

0:01:11.760 --> 0:01:14.520
<v Speaker 1>the number was lower than the week before, it was

0:01:14.680 --> 0:01:20.160
<v Speaker 1>higher than economists had predicted. Economists at Goldman Sachs Group

0:01:20.319 --> 0:01:23.880
<v Speaker 1>revised their forecast for the peak unemployment rate in the US.

0:01:24.880 --> 0:01:28.360
<v Speaker 1>They now say unemployment will hit twenty five percent before

0:01:28.400 --> 0:01:33.360
<v Speaker 1>falling again, when they previously forecast a peak of fifteen percent.

0:01:34.800 --> 0:01:38.399
<v Speaker 1>A serious but rare inflammatory disease in children, may have

0:01:38.520 --> 0:01:43.200
<v Speaker 1>jumped thirtyfold because of coronavirus, according to an Italian study.

0:01:44.280 --> 0:01:47.360
<v Speaker 1>A detailed analysis from Bergamo, the city at the center

0:01:47.400 --> 0:01:51.560
<v Speaker 1>of the Italian COVID nineteen outbreak, found ten cases of

0:01:51.600 --> 0:01:57.000
<v Speaker 1>a COVID linked illness that resembles Kawasaki disease. All told,

0:01:57.080 --> 0:02:00.000
<v Speaker 1>about a hundred such cases have been reported in It'll,

0:02:00.440 --> 0:02:05.040
<v Speaker 1>New York, and England. The cases are challenging the previous

0:02:05.160 --> 0:02:11.119
<v Speaker 1>understanding that the disease rarely made children very sick. Finally,

0:02:11.400 --> 0:02:13.840
<v Speaker 1>Asian countries that were among the first affected by the

0:02:13.840 --> 0:02:18.040
<v Speaker 1>coronavirus and the most successful in quelling its spread are

0:02:18.120 --> 0:02:23.000
<v Speaker 1>now fearing second waves. After containing their outbreaks through measures

0:02:23.040 --> 0:02:27.920
<v Speaker 1>from strict lockdowns to rapid testing regimes, Hong Kong, South Korea,

0:02:28.200 --> 0:02:32.280
<v Speaker 1>and China face resurgences of the disease even as they

0:02:32.360 --> 0:02:38.040
<v Speaker 1>pursue aggressive testing and tracing. It's a reminder that untraceable

0:02:38.040 --> 0:02:42.240
<v Speaker 1>flare ups are likely even after an extended lulling cases.

0:02:43.160 --> 0:02:47.079
<v Speaker 1>Scientists have warned that the disease may never go away

0:02:47.160 --> 0:02:50.840
<v Speaker 1>because it lurks in some people without causing any outward

0:02:50.880 --> 0:03:02.520
<v Speaker 1>signs of sickness and now our main store. The drug

0:03:02.760 --> 0:03:06.920
<v Speaker 1>um Desevere, manufactured by Gilead Sciences, has offered one of

0:03:06.919 --> 0:03:09.560
<v Speaker 1>the fewest lovers of hope about the virus to emerge

0:03:09.560 --> 0:03:13.280
<v Speaker 1>in the last few months. In a clinical trial, ram

0:03:13.320 --> 0:03:16.280
<v Speaker 1>desevere was shown to reduce the recovery time of patients

0:03:16.480 --> 0:03:21.520
<v Speaker 1>who were seriously sick with COVID nineteen. Based on that trial,

0:03:21.680 --> 0:03:25.160
<v Speaker 1>the Federal Food and Drug Administration authorized the drug for

0:03:25.200 --> 0:03:30.280
<v Speaker 1>emergency use. The promising results suggested the virus may be

0:03:30.280 --> 0:03:34.040
<v Speaker 1>beatable and even buoyed the volatile stock market for a

0:03:34.120 --> 0:03:38.800
<v Speaker 1>short while. Gilliad had enough of its drug ready to

0:03:38.840 --> 0:03:42.440
<v Speaker 1>test and start manufacturing it at a larger scale because

0:03:42.440 --> 0:03:45.800
<v Speaker 1>it had started stockpiling not just the drug but its

0:03:45.920 --> 0:03:50.120
<v Speaker 1>ingredients at the first hint there may be a new coronavirus.

0:03:51.400 --> 0:03:54.200
<v Speaker 1>I talked to Robert Langraff about why the company was

0:03:54.240 --> 0:03:57.880
<v Speaker 1>able to act early to prepare for a pandemic when

0:03:57.920 --> 0:04:07.120
<v Speaker 1>so many businesses and institutions did not. So, Bob, how

0:04:07.200 --> 0:04:10.800
<v Speaker 1>good is this drug? Well, the short inswers, we really

0:04:10.840 --> 0:04:14.480
<v Speaker 1>don't know yet. Uh. It got an emergency author's use

0:04:14.560 --> 0:04:17.920
<v Speaker 1>authorization by the Food and Drug Administration based basically on

0:04:17.960 --> 0:04:20.919
<v Speaker 1>a single trial about a thousand patients conducted by the

0:04:21.000 --> 0:04:24.360
<v Speaker 1>National Institute's of Health. According to the preliminary data, kind

0:04:24.360 --> 0:04:27.400
<v Speaker 1>of it helped speed up recovery from the disease on

0:04:27.400 --> 0:04:30.520
<v Speaker 1>the average by about four days. But none of the

0:04:30.560 --> 0:04:32.480
<v Speaker 1>data really has been published. We don't really know any

0:04:32.520 --> 0:04:34.320
<v Speaker 1>of the details of the data. And then there's another

0:04:34.400 --> 0:04:38.000
<v Speaker 1>study from China, much smaller study from China, you know,

0:04:38.040 --> 0:04:39.880
<v Speaker 1>that failed to show a clear effect of the drug,

0:04:40.400 --> 0:04:43.320
<v Speaker 1>also in hospitalized patients. So it's just the data is

0:04:43.400 --> 0:04:46.520
<v Speaker 1>very very preliminary, preliminary, preliminary. Now, you know, doctors really

0:04:46.520 --> 0:04:48.640
<v Speaker 1>haven't seen it has been invented or published, you know,

0:04:48.640 --> 0:04:51.039
<v Speaker 1>in medical journal. It is from you know, the n

0:04:51.040 --> 0:04:54.120
<v Speaker 1>i H with a very good reputation, Tony Fauci's group.

0:04:54.120 --> 0:04:56.880
<v Speaker 1>It you know, ni H help sponsor and conduct this, uh,

0:04:56.960 --> 0:04:59.240
<v Speaker 1>this study. But you know, in terms of the fine

0:04:59.320 --> 0:05:01.960
<v Speaker 1>details of whether there's a safe lives or not, you know,

0:05:02.000 --> 0:05:05.000
<v Speaker 1>we just don't know yet. So you wouldn't necessarily call

0:05:05.040 --> 0:05:07.920
<v Speaker 1>it a cure. No, I definitely would not necessarily call

0:05:07.920 --> 0:05:10.719
<v Speaker 1>it a cure. And uh, in you know discussing it,

0:05:10.839 --> 0:05:14.159
<v Speaker 1>you know, early on when they kind of announced the results, Uh,

0:05:14.360 --> 0:05:17.240
<v Speaker 1>Tony Faucci kind of like in this early trials, early trials,

0:05:17.440 --> 0:05:20.320
<v Speaker 1>you know, a z T which was one of the uh,

0:05:20.440 --> 0:05:23.200
<v Speaker 1>the first HIV drug, and that kind of was you know,

0:05:23.320 --> 0:05:26.440
<v Speaker 1>proved quickly based on early evidence, but then you know,

0:05:26.520 --> 0:05:28.720
<v Speaker 1>later on was you know, supplanted by you know, much

0:05:29.279 --> 0:05:32.799
<v Speaker 1>more potent, stronger drug combinations. The way to think about

0:05:32.839 --> 0:05:34.599
<v Speaker 1>this is kind of, hey, it's a start. You know,

0:05:34.640 --> 0:05:37.120
<v Speaker 1>it's a first, first drug we can use, and there

0:05:37.160 --> 0:05:40.520
<v Speaker 1>We're gonna need many more drugs and vaccines in the future.

0:05:41.720 --> 0:05:44.800
<v Speaker 1>So I'm wondering what are some of the issues with

0:05:45.000 --> 0:05:49.039
<v Speaker 1>producing this drug in in large quantities. It's been likened to,

0:05:49.400 --> 0:05:52.839
<v Speaker 1>you know, making you know, these very specialized complex chemicals

0:05:52.839 --> 0:05:55.800
<v Speaker 1>sort of been liking to bake in a very you know, specialized,

0:05:55.839 --> 0:05:58.120
<v Speaker 1>fancy type of bread. You have to do, uh, you know,

0:05:58.200 --> 0:06:00.440
<v Speaker 1>have to have all the right ingredients on hand in

0:06:00.560 --> 0:06:02.560
<v Speaker 1>large quantities, and if you have to wait for the

0:06:02.560 --> 0:06:04.480
<v Speaker 1>week to grow, so to speak, then you're you know,

0:06:04.520 --> 0:06:05.960
<v Speaker 1>out of luck and you may have to wait a while.

0:06:06.200 --> 0:06:07.960
<v Speaker 1>So you have to have all the ingredients on hand,

0:06:08.000 --> 0:06:09.760
<v Speaker 1>and then you have to execute all the steps in

0:06:09.800 --> 0:06:12.720
<v Speaker 1>the proper sequential order. And for this drug, there's more

0:06:12.720 --> 0:06:15.760
<v Speaker 1>steps chemical steps than usually it's about the twenty five

0:06:15.839 --> 0:06:18.880
<v Speaker 1>different chemical steps depending on how you count. So basically

0:06:18.880 --> 0:06:21.120
<v Speaker 1>at the start of the process, Gilly had Gilly had

0:06:21.160 --> 0:06:24.000
<v Speaker 1>had some supply on hand, but they estimated that to

0:06:24.040 --> 0:06:25.839
<v Speaker 1>make more of it would take you nine to twelve

0:06:25.839 --> 0:06:28.640
<v Speaker 1>months from start to finish just to gather all the

0:06:28.680 --> 0:06:31.960
<v Speaker 1>important raw materials and starting chemicals, then to produce the

0:06:32.080 --> 0:06:34.800
<v Speaker 1>raw drug supply the raw they call it active pharmactical

0:06:34.839 --> 0:06:37.599
<v Speaker 1>sudical ingredients that's just like a bulk white powder. And

0:06:37.640 --> 0:06:40.440
<v Speaker 1>then because this drug is not a pill, it's infused

0:06:40.600 --> 0:06:43.839
<v Speaker 1>into viles, that there's an additional manufacturing step that's need

0:06:43.839 --> 0:06:45.640
<v Speaker 1>and that they have to you have to dissolve it

0:06:45.680 --> 0:06:49.120
<v Speaker 1>and put it into viles under very sterile conditions. H

0:06:49.120 --> 0:06:51.520
<v Speaker 1>And that adds additional complexity to the process that you know,

0:06:51.520 --> 0:06:55.159
<v Speaker 1>a separate manufacturing plants. So all told, there's there's are

0:06:55.200 --> 0:06:58.480
<v Speaker 1>quite a number of steps, and they've been able to

0:06:58.520 --> 0:07:01.960
<v Speaker 1>get it down to about six months now by improving

0:07:02.080 --> 0:07:05.440
<v Speaker 1>the process, but you know, it's still a lengthy, complicated

0:07:05.680 --> 0:07:09.360
<v Speaker 1>process from start to finish. What was the original use

0:07:09.440 --> 0:07:12.720
<v Speaker 1>case for rem desvier? Why was bill yad developing the drug. Yeah,

0:07:12.800 --> 0:07:16.360
<v Speaker 1>so it's very interesting. They put a team together back

0:07:16.360 --> 0:07:18.040
<v Speaker 1>in two thousand and fourteen, you know, looking at some

0:07:18.080 --> 0:07:21.360
<v Speaker 1>of their drugs for emerging viruses. And you know, one

0:07:21.400 --> 0:07:23.200
<v Speaker 1>of the reasons they were looking at that is because

0:07:23.280 --> 0:07:26.640
<v Speaker 1>that was like the big bowler outbreak in West Africa.

0:07:26.720 --> 0:07:28.560
<v Speaker 1>So they put together a team, you know, fifteen or

0:07:28.560 --> 0:07:30.960
<v Speaker 1>twenty people looking at that, you know, what drugs might

0:07:30.960 --> 0:07:33.280
<v Speaker 1>be good for some of these emerging viruses and remdesiviere,

0:07:33.320 --> 0:07:35.200
<v Speaker 1>which is like in the test to work, we worked

0:07:35.240 --> 0:07:38.440
<v Speaker 1>against a lot of viruses kind of jumped to the

0:07:38.480 --> 0:07:40.800
<v Speaker 1>top of the list, but they weren't able to actually

0:07:40.880 --> 0:07:43.640
<v Speaker 1>test it in people and for easy in a bowler

0:07:43.680 --> 0:07:45.560
<v Speaker 1>until kind of the next bowl outbreak I was like

0:07:45.560 --> 0:07:49.960
<v Speaker 1>twos eighteen tousand, nineteen, uh and the congo. Interestingly enough,

0:07:50.000 --> 0:07:52.960
<v Speaker 1>it didn't work well there. They got those results you know,

0:07:53.040 --> 0:07:55.960
<v Speaker 1>last year. But in the process of testing it for

0:07:56.000 --> 0:07:58.040
<v Speaker 1>a ball, I'm looking at it for other things. Some

0:07:58.120 --> 0:08:01.200
<v Speaker 1>researchers at the head is working with at the University

0:08:01.200 --> 0:08:04.360
<v Speaker 1>of North Carolina and Vanderbilt University Medical Center, you know,

0:08:04.480 --> 0:08:06.920
<v Speaker 1>showed that it was really quite effective at least in

0:08:06.920 --> 0:08:09.880
<v Speaker 1>the lab and the test tube type tests against a

0:08:09.920 --> 0:08:13.800
<v Speaker 1>whole variety of coronaviruses. When this COVID nineteam came aroung

0:08:14.160 --> 0:08:17.320
<v Speaker 1>Long deserverre basically immediately became a you know, a prime

0:08:17.400 --> 0:08:29.840
<v Speaker 1>candidate to test as a drug against COVID nineteen. And

0:08:30.080 --> 0:08:33.880
<v Speaker 1>currently how much supply is there of M devere So

0:08:34.080 --> 0:08:37.920
<v Speaker 1>gill Lead is promising to donate the first one point

0:08:38.000 --> 0:08:40.880
<v Speaker 1>five million vials of the drug, and that's you know,

0:08:41.040 --> 0:08:44.720
<v Speaker 1>roughly enough to treat close to two hundred patients, you know,

0:08:44.760 --> 0:08:48.320
<v Speaker 1>under a kind of existing regiments, And the US Department

0:08:48.320 --> 0:08:51.319
<v Speaker 1>of Health and Humanity Services said that about six hundred

0:08:51.400 --> 0:08:54.960
<v Speaker 1>thousand uh of those vials are going to earmarks so

0:08:55.040 --> 0:08:57.280
<v Speaker 1>to speak, for the United States, that maybe that will

0:08:57.280 --> 0:08:59.760
<v Speaker 1>treat about seventy eight thousand patients here. So, you know,

0:09:00.120 --> 0:09:03.320
<v Speaker 1>there's already a lot of debate over you know, which

0:09:03.320 --> 0:09:05.600
<v Speaker 1>hospitals are getting it and why. Now Guilliad is not

0:09:05.960 --> 0:09:08.520
<v Speaker 1>deciding that. The US government and the state governments are

0:09:08.520 --> 0:09:11.520
<v Speaker 1>deciding that, but there's been a lot of confusion over

0:09:11.600 --> 0:09:13.360
<v Speaker 1>you know what what you know, how is it being

0:09:13.400 --> 0:09:15.560
<v Speaker 1>allocated different hospitals, and why do some parts of the

0:09:15.559 --> 0:09:18.720
<v Speaker 1>country have a supply of this now and others don't

0:09:18.800 --> 0:09:22.439
<v Speaker 1>how is that being decided. So Gillian is working very

0:09:22.520 --> 0:09:25.920
<v Speaker 1>hard to increase the supply. One key decision, you know,

0:09:25.920 --> 0:09:28.960
<v Speaker 1>it made early on, was very early in January, as

0:09:29.000 --> 0:09:30.480
<v Speaker 1>soon as it became clearly this thing, you know, it

0:09:30.600 --> 0:09:33.360
<v Speaker 1>was caused by coronavirus and could potentially be significant, they

0:09:33.400 --> 0:09:36.600
<v Speaker 1>put out a big, big order, like all the bulk supplies.

0:09:36.840 --> 0:09:38.400
<v Speaker 1>They need to make a lot more of this drug,

0:09:38.880 --> 0:09:40.800
<v Speaker 1>sort of like the equivalent of you know, all the

0:09:40.840 --> 0:09:43.040
<v Speaker 1>specialized flower and all the specialized eggs and all the

0:09:43.040 --> 0:09:45.240
<v Speaker 1>specialized butter and all the other ingredients that go into

0:09:45.240 --> 0:09:47.800
<v Speaker 1>your baking. They put a big, big order and because

0:09:47.800 --> 0:09:49.880
<v Speaker 1>of that, you know, they're now in a position to start,

0:09:49.920 --> 0:09:52.480
<v Speaker 1>you know, making much bigger supplies of it. And they're

0:09:52.520 --> 0:09:55.040
<v Speaker 1>talking about having by fall enough to treat five hund

0:09:55.120 --> 0:09:56.840
<v Speaker 1>thousand patients, but into the year enough to treat at

0:09:56.880 --> 0:09:59.199
<v Speaker 1>least a million patients. So that's still going to take

0:09:59.200 --> 0:10:00.960
<v Speaker 1>a number of months to role in. So it's still

0:10:01.080 --> 0:10:04.160
<v Speaker 1>right now, it's definitely in short supply. Now you mentioned

0:10:04.160 --> 0:10:07.200
<v Speaker 1>that Gilliat is willing to donate a certain amount of

0:10:07.280 --> 0:10:10.560
<v Speaker 1>the drug initially, but eventually they are going to have

0:10:10.600 --> 0:10:13.400
<v Speaker 1>to charge for the drug. Is there any estimate of

0:10:13.440 --> 0:10:16.319
<v Speaker 1>how much this drug is going to cost? Now Guilliad

0:10:16.400 --> 0:10:17.960
<v Speaker 1>is not talking about it, and so it's too early

0:10:18.000 --> 0:10:20.400
<v Speaker 1>to talk about that. But uh, Wall Street, you know,

0:10:20.559 --> 0:10:22.800
<v Speaker 1>is talking about that, and they're they're figuring, you know,

0:10:22.840 --> 0:10:25.120
<v Speaker 1>it might be around three or four or five thousand

0:10:25.160 --> 0:10:28.400
<v Speaker 1>dollars per course of treatment, you know, at least for

0:10:28.600 --> 0:10:32.559
<v Speaker 1>you know, wealthier countries like the United States and Europe. So,

0:10:32.600 --> 0:10:35.560
<v Speaker 1>as you mentioned, REM descivite is not a cure for

0:10:35.600 --> 0:10:40.000
<v Speaker 1>COVID nineteen. And so in your estimate or your recommendation,

0:10:40.720 --> 0:10:43.360
<v Speaker 1>what are some other drugs or vaccines? What more research

0:10:43.440 --> 0:10:46.680
<v Speaker 1>is needed to be done to maybe compliment REM decivere

0:10:46.840 --> 0:10:50.360
<v Speaker 1>or maybe to actually find a cure for COVID nineteen. Well,

0:10:50.480 --> 0:10:54.360
<v Speaker 1>there's just an immense I call almost a fire hose

0:10:54.400 --> 0:10:57.440
<v Speaker 1>of drugs and trials and vaccines being tested. Now there's

0:10:57.440 --> 0:10:59.640
<v Speaker 1>like literally more more than a hundred drugs and hundred

0:10:59.720 --> 0:11:03.440
<v Speaker 1>vaccine means being either tested and trials are you know,

0:11:03.520 --> 0:11:07.120
<v Speaker 1>explored in preclinical trials. Um one approach on the drug

0:11:07.200 --> 0:11:09.600
<v Speaker 1>front that a number of companies are working on is

0:11:09.640 --> 0:11:13.680
<v Speaker 1>called monocle antibodies. This is antibodies would be directly against

0:11:13.720 --> 0:11:17.880
<v Speaker 1>COVID nineteen. Companies working on that include every General and

0:11:17.880 --> 0:11:21.880
<v Speaker 1>Pharmaceuticals which made a successful treatment for a bowl are

0:11:21.960 --> 0:11:25.480
<v Speaker 1>using the same type of approach, and so monoclon antibodies

0:11:25.520 --> 0:11:29.000
<v Speaker 1>they be essentially when when you when you get get

0:11:29.000 --> 0:11:32.079
<v Speaker 1>the virus and the coverent from it, you have antibodies

0:11:32.080 --> 0:11:34.959
<v Speaker 1>to that virus that basically block the spike protein of

0:11:35.040 --> 0:11:37.720
<v Speaker 1>the virus, which is how the virus gets into cells.

0:11:37.840 --> 0:11:41.680
<v Speaker 1>And so what these artificially made monoclon antibodies would be

0:11:41.720 --> 0:11:46.320
<v Speaker 1>would essentially duplicate the natural process of creating antibodies, and

0:11:46.480 --> 0:11:49.240
<v Speaker 1>except they pick out some antibodies and make you know,

0:11:49.400 --> 0:11:51.960
<v Speaker 1>large quantities of them the factory and just inject them

0:11:52.160 --> 0:11:55.400
<v Speaker 1>directly into you. And you could use these monoclon antibodies

0:11:55.400 --> 0:11:57.600
<v Speaker 1>two different ways. They could be used as a preventative

0:11:57.640 --> 0:11:59.800
<v Speaker 1>treatment for people at very high risks, such as like

0:12:00.040 --> 0:12:03.000
<v Speaker 1>versus doctor's first responders, and they could also be used

0:12:03.040 --> 0:12:06.200
<v Speaker 1>to treat very sick patients UH with the disease and

0:12:06.760 --> 0:12:09.760
<v Speaker 1>re General has talked about starting clinical trials with that

0:12:09.880 --> 0:12:12.760
<v Speaker 1>approach in June, and there are several other drug companies

0:12:12.800 --> 0:12:15.600
<v Speaker 1>also working on similar approaches. And these antibodes are viewed

0:12:15.600 --> 0:12:19.439
<v Speaker 1>as one of the most promising treatment approaches or proven nineteen.

0:12:28.640 --> 0:12:32.880
<v Speaker 1>That was Bloomberg's Robert Langrath. His reporting on gile lead

0:12:33.120 --> 0:12:35.880
<v Speaker 1>is the cover story of this week's issue of Bloomberg

0:12:35.920 --> 0:12:40.000
<v Speaker 1>Business Week. And that's our show today. For coverage of

0:12:40.000 --> 0:12:44.160
<v Speaker 1>the outbreak from bureaus around the world, visit Bloomberg dot

0:12:44.200 --> 0:12:49.000
<v Speaker 1>com slash coronavirus and if you like the show, please

0:12:49.080 --> 0:12:51.720
<v Speaker 1>leave us a review and a rating on Apple Podcasts

0:12:51.800 --> 0:12:55.200
<v Speaker 1>or Spotify. It's the best way to help more listeners

0:12:55.360 --> 0:12:59.679
<v Speaker 1>find our global reporting. The Prognosis Daily edition is of

0:12:59.840 --> 0:13:03.320
<v Speaker 1>to Me Laura Carlson. The show was produced by Me

0:13:03.720 --> 0:13:09.640
<v Speaker 1>Topher foreheads, Jordan Gaspore and Magnus Hendrickson. Today's main story

0:13:09.880 --> 0:13:14.240
<v Speaker 1>was reported by Robert Langrith. Original music by Leo Sidrin.

0:13:14.840 --> 0:13:19.640
<v Speaker 1>Our editors are Francesca Levi and Rick Shine. Francesca Levi

0:13:20.000 --> 0:13:23.200
<v Speaker 1>is Bloomberg's head of Podcasts. Thanks for listening.